Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
12/02/2009 | EP2124962A1 Use of biglycan or enhancers of biglycan activity in the preparation of pharmaceutical compositions |
12/02/2009 | EP2124959A1 Pharmaceutical composition |
12/02/2009 | EP2124955A2 Inhibition of pde2a |
12/02/2009 | EP2124951A1 5-cyan0-4- (pyrrolo ý2, 3b¨pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors |
12/02/2009 | EP2124948A1 Compositions for treating hyperproliferative vascular disorders and cancers |
12/02/2009 | EP2124931A1 Pharmaceutical compositions comprising nebivolol or a nebivolol analogue |
12/02/2009 | EP2124923A1 Use of a polyphenol in the treatment of the metabolic syndrome and endothelial dysfunction or other vascular sequellae. |
12/02/2009 | EP2124917A1 Soluble epoxide hydrolase inhibitors for treatment of metabolic syndrome and related disorders |
12/02/2009 | EP2124549A1 Anti-hypercholesterolemic compounds |
12/02/2009 | EP1618086B1 Compounds for the treatment of metabolic disorders |
12/02/2009 | EP1606284B1 Compositions useful as protein kinase inhibitors |
12/02/2009 | EP1463440B1 Prevention of flap necrosis in plastic surgery |
12/02/2009 | EP1446380B1 Formoterol tartrate process and polymorph |
12/02/2009 | EP1389203B1 Analogs of thalidomide as angiogenesis inhibitors |
12/02/2009 | EP1349841B1 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto |
12/02/2009 | EP1272179B1 Hydrophilic molecular disperse solutions of carvedilol |
12/02/2009 | CN101594909A IRAK modulators for treating an inflammatory condition, cell proliferative disorder, immune disorder |
12/02/2009 | CN101594871A Pyrrolopyrimidine compounds and their uses |
12/02/2009 | CN101594858A Soluble epoxide hydrolase inhibitors for treatment of metabolic syndrome and related disorders |
12/02/2009 | CN101594857A Crystalline forms of aliskiren hemifumarate |
12/02/2009 | CN101594782A Oil-and-fat composition, and food or beverage containing the oil-and-fat composition |
12/02/2009 | CN101591386A Polypeptide capable of inhibiting excitable and toxic damages and use thereof |
12/02/2009 | CN101591374A Steroid compound, preparation method thereof, medicinal composition containing compound and application of compounds |
12/02/2009 | CN101591370A Synthetic method of puerarin derivatives |
12/02/2009 | CN101591368A Girald pteroxygonum root neoflavonoid compound |
12/02/2009 | CN101591337A Compound formed by splicing ferulic acid and matrine compound and application thereof |
12/02/2009 | CN101591324A Three crystal forms of 5-methyl-7-methoxy-isoflavone, preparation method thereof, medicine composition thereof and application |
12/02/2009 | CN101591323A Five crystal forms of 7-hydroxy-isoflavone, preparation method thereof, medicine composition thereof and application |
12/02/2009 | CN101591320A Scutellarein |
12/02/2009 | CN101591310A Method for preparing cinepazide maleate |
12/02/2009 | CN101591302A Preparation technique of heptenoic acid ester derivative |
12/02/2009 | CN101591301A Preparation method of 3, 5-dihydroxy heptyl-6-gadoleic acid derivative |
12/02/2009 | CN101590240A Composition containing angiotensin II receptor antagonist, statin and folic acid as well as applications thereof |
12/02/2009 | CN101590239A Pharmaceutical composition containing uretic, statin and folic acid as well as applications thereof |
12/02/2009 | CN101590238A Composition containing angiotensin converting enzyme inhibitor, statin and folic acid as well as applications thereof |
12/02/2009 | CN101590236A Composition containing calcium antagonist and Statins and application thereof |
12/02/2009 | CN101590232A Pharmaceutical composition containing angiotensin converting enzyme inhibitors, lipid-lowering statins and nicotinic acid and application thereof |
12/02/2009 | CN101590231A Pharmaceutical composition containing angiotensin II receptor blockers, lipid-lowering statins and nicotinic acid and application thereof |
12/02/2009 | CN101590230A Pharmaceutical composition containing renin inhibitor, diuretic agent and folic acid and application thereof |
12/02/2009 | CN101590210A Chinese medicinal composition for treating cerebraledema and preparation method thereof |
12/02/2009 | CN101590188A Chinese medicament for refreshing brain and benefiting intelligence and production technology thereof |
12/02/2009 | CN101590182A Application of traditional Chinese medicine composition in preparing medicine for reducing malignant cytokine level |
12/02/2009 | CN101590181A Application of traditional Chinese medicine composition in preparing medicine for improving cytokine expression |
12/02/2009 | CN101590180A Application of traditional Chinese medicine composition in preparing medicine for inhibiting cardiac muscle cell apoptosis |
12/02/2009 | CN101590178A Application of traditional Chinese medicine composition in preparation of medicine for treating refractory premature beat of elderly patient |
12/02/2009 | CN101590173A Application of traditional Chinese medicine composition in preparing medicine for treating hypertensive intracerebral hemorrhage |
12/02/2009 | CN101590163A Medicament for treating dementia and preparation method thereof |
12/02/2009 | CN101590158A Method for extracting polyphenol from canna edulis ker waste residue |
12/02/2009 | CN101590156A Patch for treating miocardial infarction and manufacturing method |
12/02/2009 | CN101590155A Patch for treating miocardial infarction |
12/02/2009 | CN101590152A Preparation method of Bawei Chenxiang capsule |
12/02/2009 | CN101590127A Compound medicine containing total flavone of hawthorn (leaf) and folic acid compound |
12/02/2009 | CN101590124A Application of traditional Chinese medicine composition in preparing medicament for improving prognosis of myocardial infarction |
12/02/2009 | CN101590123A Application of traditional Chinese medicine composition in preparing medicament for protecting damaged vascular endothelium |
12/02/2009 | CN101590121A Application of traditional Chinese medicine composition in preparing medicament for protecting integrality of barrier function of endothelial cells |
12/02/2009 | CN101590120A Application of traditional Chinese medicine composition in preparing medicament for proliferating endothelial progenitor cells of peripheral blood of human body |
12/02/2009 | CN101590110A Method for extracting bioflavonoid from mulberry |
12/02/2009 | CN101590104A Chinese medicament for treating obstructive angiitis |
12/02/2009 | CN101590102A Medicine for treating heart cardiovascular and cerebrovascular diseases and preparation method thereof |
12/02/2009 | CN101590097A Chinese herbal medicine prescription for reducing blood pressure and blood fat and improving sleep |
12/02/2009 | CN101590095A Compound medicine containing gypenosides and folic acid compound |
12/02/2009 | CN101590084A Pharmaceutical composition containing angiotensin converting enzyme inhibitors, B vitamins and ginkgo biloba extracts |
12/02/2009 | CN101590083A Yinxingdamo oral preparation equivalent to similar intravenous preparation |
12/02/2009 | CN101590082A Preparation for improving blood fat, blood pressure and blood sugar and protecting cardiovascular and cerebrovascular blood vessels and preparation method thereof |
12/02/2009 | CN101590071A Application of icariin in preparing medicaments for treating acute cerebral infarction |
12/02/2009 | CN101590060A Composition of ligustrazine and salvanolic acid B and application thereof |
12/02/2009 | CN101590054A Lovastatin and niacin sustained-release tablet and preparation method thereof |
12/02/2009 | CN101590044A Pharmacologic usage of berberine |
12/02/2009 | CN101590042A Stable oral medicinal composition |
12/02/2009 | CN101590038A Oral sustained release hypotensive composition |
12/02/2009 | CN101590032A Sustained-release tablet recipe for treating chest stasis obstruction symptom and preparation process thereof |
12/02/2009 | CN101590030A Pharmaceutical composition containing aliskiren, hydrochlorothiazide and folic acid and application thereof |
12/02/2009 | CN101590024A Syringin preparation and preparation method thereof |
12/02/2009 | CN101589898A Multifunctional health care Chinese medicament pillow |
12/02/2009 | CN101589830A Beverage for regulating primary hypertension |
12/02/2009 | CN101589799A Multi-nutrient breakfast |
12/02/2009 | CN100564397C Low molecular weight heparin triethanolamine salt usable as local delivery antithrombotic treating agent, preparing process and use thereof |
12/02/2009 | CN100564381C N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
12/02/2009 | CN100564375C (3Z) -3-(2,3-dihydro-1H-ylidene)-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
12/02/2009 | CN100563709C Novel targeted tissue factor antibody as anticoagulants |
12/02/2009 | CN100563701C Traditional Chinese medicine for preventing relapse of coronary disease |
12/02/2009 | CN100563699C Application of medication composition of containing ligusticum in preparing medicine for treating chronic cerebral circulation insufficin |
12/02/2009 | CN100563692C Application of medication composition of containing magnet in preparing medicine for treating insufficiency of blood supply for brain |
12/02/2009 | CN100563682C Medicine compound made of haw leaf and rhodiola and its preparation method |
12/02/2009 | CN100563673C Preparation of Chinese traditional medicine for treating coronary heart disease and angina and its preparation method |
12/02/2009 | CN100563669C Process for preparing blumea balsamifera total flavone extract and blumea balsamifera flavone extract |
12/02/2009 | CN100563668C Ginseng preparation using vinegar and process thereof |
12/02/2009 | CN100563666C Preparing method of blood circulation promoting injection |
12/02/2009 | CN100563664C Liquid medicine preparation and its preparing process and use |
12/02/2009 | CN100563662C Effective elements composition of Chinese traditional medicine for curing cardiovascular disease and the preparation method |
12/02/2009 | CN100563659C Use of ferriporphyrin short peptide compound in preparation of medicament for resisting coronary heart disease |
12/02/2009 | CN100563647C Medicine composition of erigeron breviscapus and tanshinone IIA sodium sulfoacid |
12/02/2009 | CN100563643C Use of eNOS transcription enhancers in the cell therapy of ischemic heart diseases |
12/02/2009 | CN100563638C Nifedipine controlled-releasing tablet and preparation method thereof |
12/02/2009 | CN100563633C Hydrochloric acid diltiazem freeze-dried powder injection for injections and preparation method thereof |
12/02/2009 | CN100563466C Beverages containing plant sterols |
12/01/2009 | US7626044 Plant extracts comprising highly bioactive triptolide derivatives with low toxicity;(5-R)-5-hydroxytriptonide, (5R)-5-hydroxytriptolide, (5R)-5-hydroxy-14-epitriptolide. Delta 5,6-dehydrotriptonide, Delta 5,6-dehydrotriptolide; antiinflammatory agents; immunosuppressants; drug design |
12/01/2009 | US7626041 Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment |
12/01/2009 | US7625948 Ester that inhibits MTP in intestines as antilipemic agents for side effect reduction |
12/01/2009 | US7625934 Metalloproteinase inhibitors |